Heyuan Biotechnology is a national high-tech enterprise specializing in the R&D of plant-derived recombinant protein expression technology. It has established a complete industrialization system and quality assurance system for plant-derived biopharmaceuticals in my country. The plant-derived recombinant protein production line has become an internationally renowned biomedical R&D center focusing on plant-based drug R&D and product development.

Agennix AG is a publicly traded biopharmaceutical company that is developing novel therapies in areas of major unmet medical need to improve the length and quality of life of seriously ill patients. The Company's most advanced program is talactoferrin, an oral targeted therapy that has demonstrated activity in randomized, double-blind, placebo-controlled Phase 2 studies in non-small cell lung cancer as well as in severe sepsis. Talactoferrin is currently in Phase 3 clinical trials in non-small cell lung cancer. Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers. Agennix's registered seat is in Heidelberg, Germany. The Company has three sites of operation: Martinsried/Munich, Germany; Princeton, New Jersey and Houston, Texas.

EASY BIO, Inc. engages in the production and distribution of animal feeds. It operates through the Piglet Feed and Additives divisions. The Piglet Feed division produces i-one. The Additives division produces lipidol and endo power. The company was founded in 1988 and is headquartered in Seoul, South Korea.

Manufactures pharmaceuticals for treating degenerative brain diseases

Wuxi Kejienuo Biotechnology Co., Ltd., established on 2010-12-30, The business scope includes R&D and technical services of animal bioreactor technology and products;food,food additives,Healthy food,medicine,R&D of cosmetics.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hansol Chemical Co., Ltd. engages in the manufacture of chemical products. Its products include hydrogen peroxide, synthetic latex, paper making, polyacrylamide, benzoyl peroxide, sodium dithionite, electronic materials, and film materials. The company was founded on March 13, 1980 and is headquartered in Seoul, South Korea.

Operates as non classifiable establishments

Beijing Jipulin Biotechnology Co., Ltd., established on 2005-04-25, Business scope includes research,develop food,New Drugs and Genetic Engineering Vaccines,Biomedical Materials and Products,Bioengineering and Biomedical Engineering Technology,Breeding technology of excellent breeding stock and poultry,biological feed,protein feed;Provide technology transfer,technical consulting,Technical Services.(Non-monetary contribution1833.33ten thousand RMB,non-patent technology.;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Beijing Jifulin Biotechnology Co., Ltd., established on 2009-12-25, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;sell cosmetics,fertilizer.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Shanghai Kaisheng Biotechnology Co., Ltd., established on 2011-08-18, Business scope includes biological,Technology development in the field of chemical science and technology,technology transfer,technical consulting,Technical Services,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Sales of Feed and Additives,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Medifron DBT Co., Ltd. engages in the provision of information technology (IT) content services. It operates through the IT and New Medicine business divisions. The IT business division offers interactive voice response system which provides consultation, voicemail, automatic guidance, video conferencing, predictive dialing, audiotext, voice processing function, help desk function, collaborative computing, call switching, and call control. The New Medicine business division develops drugs and diagnostic device for the treatment of central nervous system diseases. The company was founded on March 18, 1997 and is headquartered in Seoul, South Korea.

Beijing Saibei Biotechnology Co., Ltd., established on 2013-05-27, Business scope includes biotechnology promotion,technology development,Technical Services,technology transfer,technical consulting;Import and export,Technology Import and Export,Agent import and export;Sales of biological products(Except for approval).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Tianjin Yaoyu Biotechnology Co., Ltd., established on 2009-06-05, Business scope includes research and development of biological products,Technology transfer and technical consulting services;medical instruments,drug development,technical consulting,transfer;biological reagent(food,except medicines)Wholesale and retail;account Serive;Timber wholesale and retail;Self-operated and agency goods import and export and technology import and export;Wholesale and retail of prepackaged food and bulk food.(If the above business scope involves industry licensing, the license certificate,Operate within the validity period,If the state has monopoly regulations, it shall be handled according to the regulations).

Ventria Bioscience is a privately held biopharmaceutical company with a product pipeline enabled by ExpressTec. ExpressTec is a patented, plant-based recombinant protein manufacturing technology that delivers a ten-fold higher recombinant protein yield than other plant-based systems. Ventria Bioscience's platform technology delivers meaningful and sustainable economic advantages by enabling new product opportunities that were not previously available. It can be used to develop new biotherapeutics, novel vaccines, reagents for biomanufacturing, and industrial and biofuel enzymes.

Shanghai Jielong Bioengineering Co., Ltd., established on 1999-01-15, Business scope includes research,Development of various biological products(Except for protein products of animal origin),animal and plant species,Livestock products,Raising economic animal feed purchase(except food),Scientific research biochemical instrument reagents(In addition to dangerous goods)distribution,acting,information,invest,technology transfer,food circulation,sales of feed,Metal Material Sales,Own house rental,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]